Prostate cancer is a malignant growth that develops in the prostate gland, a small organ located below the bladder that plays a role in male reproductive function. It is one of the most common cancers in men and can range from slow-growing tumors that require monitoring to more aggressive disease that needs prompt treatment. Many cases are identified through screening before symptoms develop, allowing for early intervention and improved outcomes.
Causes
The exact cause of prostate cancer is not fully understood, but several risk factors are associated with its development:
- Age: Risk increases significantly after age 50
- Family history: A history of prostate cancer in first-degree relatives increases risk
- Genetic mutations: BRCA1, BRCA2, and other inherited mutations
- Race: Higher incidence and more aggressive disease patterns in certain populations
- Hormonal factors: Androgens such as testosterone may influence tumor growth
- Lifestyle factors: Obesity and diet may contribute, though associations vary
Symptoms
Early prostate cancer often causes no symptoms. When symptoms do occur, they may include:
- Difficulty urinating or weak urinary stream
- Frequent urination, especially at night
- Blood in the urine or semen
- Erectile dysfunction
- Pelvic discomfort
- Bone pain in advanced or metastatic disease
Diagnosis
Evaluation for prostate cancer typically includes:
- Prostate-specific antigen (PSA) test: A blood test used for screening and monitoring
- Digital rectal exam (DRE): Physical assessment of the prostate for abnormalities
- MRI of the prostate: Helps identify suspicious lesions and guide biopsy
- Prostate biopsy: Confirms the presence of cancer and determines grade
- Staging studies: Imaging such as CT, bone scan, or PET scan to evaluate spread
Treatment Options
Treatment depends on cancer grade, stage, patient health, and preferences:
- Active surveillance: Monitoring low-risk cancers with periodic testing
- Radical prostatectomy: Surgical removal of the prostate gland
- Radiation therapy: External beam or brachytherapy
- Hormone therapy (androgen deprivation therapy): Reduces testosterone levels
- Chemotherapy or immunotherapy: For advanced or metastatic disease
- Focal therapy: Selected cases using targeted treatment to part of the prostate
When to See a Specialist
Men with elevated PSA levels, abnormal prostate exams, urinary symptoms, or a strong family history should be evaluated by a urologist. Early detection allows for a broader range of treatment options, including less invasive approaches when appropriate. Long-term follow-up is essential for monitoring disease progression, treatment response, and overall prostate health.